Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combined Intrathecal Dexmedetomidine and Adductor Canal Block for TKA Analgesia
NCT06837844Recruiting
- Sponsor
- Kafrelsheikh University
- Start
- Feb 2025
- Primary completion
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of dexmedetomidine in postoperative pain (3 arms), sponsored by Kafrelsheikh University. Primary endpoint: Total morphine consumption at 48 hours. Started Feb 2025; status: recruiting.
02
Drugs
dexmedetomidine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06837844.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06837844.